Quick Answer
enVVeno Medical Corp reported Research And Development Expense of $9.98 million for the year ending 2025.
- enVVeno Medical Corp showed a decrease of -18.5% in Research And Development Expense from 2024 to 2025.
- This data is from enVVeno Medical Corp's annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 9 years of available data (2017 to 2025), enVVeno Medical Corp's Research And Development Expense has grown by 1,436.2%.
- Historical annual values: Fiscal year 2025: $9.98 million | Fiscal year 2024: $12.25 million | Fiscal year 2023: $13.58 million | Fiscal year 2022: $9.91 million | Fiscal year 2021: $5.73 million | Fiscal year 2020: $4.25 million | Fiscal year 2019: $2.21 million | Fiscal year 2018: $1.24 million | Fiscal year 2017: $649.7 thousand.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: